Clinical Trials Directory

Trials / Completed

CompletedNCT04745273

Interaction Between Tramadol and Ondansetron

The Effect of Ondansetron on the Efficacy of Tramadol

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Acibadem University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In the postoperative period; pain, nausea, and vomiting are undesirable side effects that reduce the patient's comfort and may lead to various complications. Ondansetron is frequently used as an antiemetic and tramadol hydrochloride is used for postoperative analgesia in laparoscopic cholecystectomy. However, some studies have reported that there is a drug interaction between these two drugs and they reduce each other's effects, thus requiring more analgesics in the postoperative period. The aim of this study is; To evaluate whether ondansetron reduces the analgesic efficacy of tramadol hydrochloride in laparoscopic cholecystectomies.

Detailed description

During the operation, 4 mg iv ondansetron (2mL) will be administered to the ondansetron group and 2mL iv 09% saline will be administered to the placebo group. The patients' heart rate, blood pressure, oxygen saturation, sedation score (with Ramsey Seading Score), amount of pain (with NRS), degree of nausea (with NRS), whether there is vomiting, whether analgesic or antiemetic treatment is required, and the amount of tramadol use will be recorded at 1, 2, 4, 8, 12 and 24 hours in the postoperative period.

Conditions

Interventions

TypeNameDescription
DRUGOndansetron 4 MG (Kemoset 4mg)Ondansetron 4mg (iv) will administer to participants
OTHERSalin solutionSalin solution 2ml (iv) will administer to participants

Timeline

Start date
2020-09-02
Primary completion
2021-06-25
Completion
2021-06-25
First posted
2021-02-09
Last updated
2022-11-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04745273. Inclusion in this directory is not an endorsement.

Interaction Between Tramadol and Ondansetron (NCT04745273) · Clinical Trials Directory